Article Image

Kate McKinnon will play disgraced Theranos founder Elizabeth Holmes for Hulu

Saturday Night Live superstar Kate McKinnon has been tapped to star in Hulu's The Dropout, a limited series that will chronicle the rise and fall of Theranos founder and alleged fraudster, Elizabeth Holmes.

Kate McKinnon is best known for her all-star performances on Saturday Night Live as well as turns in comedies like Ghostbusters, Rough Night, and The Spy Who Dumped Me, but there’s nothing funny about her next role. The comedian will play former Theranos CEO Elizabeth Holmes, who was indicted by a federal grand jury for fraud in 2018, in a limited series for Hulu, Deadline reports.

The Dropout, which is based on the podcast of the same name, will chronicle Holmes’ transformation from a 19-year-old science prodigy to the CEO of her own health technology company, as well as her fall from grace when journalists and regulators began to question Theranos’ legitimacy. McKinnon will co-produce the series alongside ABC News’ Rebecca Jarvis, who created The Dropout, and producers Taylor Dunn and Victoria Thompson. The series is expected to run for six to 10 episodes.

Holmes dropped out of Stanford in 2004 and used her tuition money to found Theranos, which promised to revolutionize blood testing technology. By 2014, Holmes had raised more than $400 million in venture capital funding, and Theranos, which had signed a lucrative deal with Walgreens, was valued at $9 billion.

Things quickly unraveled in 2015, however, when the Wall Street Journal published an article claiming that Theranos’ signature blood-testing device, which could allegedly derive low-cost blood tests from small drops of blood, wasn’t as reliable as the company claimed.

Meanwhile, Holmes’ personal behavior, which she modeled after her idol Steve Jobs, grew increasingly bizarre. Eventually, federal investigators got involved, the Walgreens deal fell apart, and Theranos ultimately folded. Holmes now faces up to 20 years in prison for defrauding investors and providing inaccurate medical results. Holmes pled innocent, and the trial is still ongoing.

The Theranos saga is an interesting story, which is probably why Hollywood seems so eager to adapt it. In addition to the upcoming McKinnon series, The Dropout was reimagined as a two-hour documentary that aired on 20/20 in March, while Jennifer Lawrence and Vice director Adam McKay are collaborating on a big-screen retelling of Holmes’ story with the title Bad Blood. And if those are hits? Well, there are plenty of other Silicon Valley horror stories for Hollywood to choose from.

China just gave Hollywood a cautionary tale about AI filmmaking. Sanxingdui: Future Past, billed as the country's first fully AI-generated movie, hit theaters on October 23 and bombed at the box office.

According to Futurism, the film's reported $1.5 million production budget landed on more than 10,000 screens. Yet it pulled in only about $181,000, averaging roughly $20 per screen, making the budget difficult to recover.

Some of the best shots in Grok Imagine’s AI-made Odyssey don’t contain actors. Ancient landscapes stretch into the distance. Close-ups of grimy hands suggest people who have touched something rougher than a keyboard. For a few seconds, the illusion holds.

https://twitter.com/imagine/status/2113712964419063911

YouTube videos could soon look better without eating quite so much data, right? Thankfully, the platform plans to introduce a new video format called AV2 on its web player in early 2027, promising more efficient streaming and potentially fewer playback hiccups on slower internet connections. The big headline is a roughly 30% improvement in compression efficiency over AV1, YouTube's existing video format. That doesn't guarantee every video will use 30% less data, but it could make streaming a little easier on both internet connections and data allowances.

What is AV2, and why should viewers care?